Pandemic Darlings The pandemic economy, in original documents
Home Source documents HB 2273 — H COMM AMD by Committee on Innovation, Technology & Economic Development (Slatter)

HB 2273 — H COMM AMD by Committee on Innovation, Technology & Economic Development (Slatter)

Summary

Committee amendment to HB 2273, sponsored by Representative Slatter, offered by the Committee on Innovation, Technology & Economic Development. It strikes material on page 2 through the word "editing" and inserts a new item for scientific and technical experts in the biotechnology industry who have an understanding of human genome editing and gene therapies development. The printed EFFECT statement says the amendment removes the provision requiring the study committee to consider additional regulatory approaches to human genome editing. It also requires the study committee membership to include scientific and technical experts in the biotechnology industry.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“HB 2273 — H COMM AMD by Committee on Innovation, Technology & Economic Development (Slatter).” Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2020-01-21-a26336-d209673-2273-amh-ited-h4088-2-bb93906e25/, SHA-256 8858f9670059821dcb57be1ecd65050feaead2835b4f1b7752aaa6c4c9aae973.

Full text

    2273 AMH ITED H4088.2

                                                         By Representative Slatter

    HB 2273 - H COMM AMD
        By Committee on Innovation, Technology & Economic Development




1       On page 2, beginning on line 18, after "uses" strike all material
2   through "editing" on line 20

3       On page 2, line 29, after "technologies;" strike "and"

4       On   page   2,   line   30,   after    "(iii)"   insert   "Scientific   and
5   technical experts in the biotechnology industry who have an
6   understanding of human genome editing and gene therapies development;
7   and
8       (iv)"


        EFFECT: Removes the provision requiring the study committee to
    consider additional regulatory approaches to human genome editing.
    Requires the study committee membership to include scientific and
    technical experts in the biotechnology industry.



                                      --- END ---




    Code Rev/ML:jlb                        1                 H-4088.2/20 2nd draft

File and source

File
2020-01-21_a26336_d209673_2273-amh-ited-h4088-2.pdf
Size
50,350 bytes
SHA-256
8858f9670059821dcb57be1ecd65050feaead2835b4f1b7752aaa6c4c9aae973
Our copy
2020-01-21_a26336_d209673_2273-amh-ited-h4088-2.pdf
Original
No public link identified.
Back to top